Literature DB >> 15657162

Narrative review: pharmacotherapy for chronic heart failure: evidence from recent clinical trials.

Andrew T Yan1, Raymond T Yan, Peter P Liu.   

Abstract

Heart failure is an important cause of morbidity and mortality. Clinical trials over the past 2 decades have revolutionized the care of patients with systolic heart failure, and substantial data support the use of angiotensin-converting enzyme inhibitors, beta-blockers, angiotensin-receptor blockers, and aldosterone blockers in the management of this serious condition. This article reviews the evidence on the pharmacologic treatment of heart failure, with a focus on recent clinical trials.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15657162     DOI： 10.7326/0003-4819-142-2-200501180-00013

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


  6 in total

1.  Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection.

Authors:  Xianli Wang; Qian Wang; Wei Guo; Yi Zhun Zhu
Journal:  Biosci Rep       Date:  2011-04       Impact factor: 3.840

2.  Pilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure.

Authors:  Shaan Chugh; Maral Ouzounian; Zhen Lu; Shanas Mohamed; Wenping Li; Nicolas Bousette; Peter P Liu; Anthony O Gramolini
Journal:  Proteomics       Date:  2013-07-01       Impact factor: 3.984

3.  Relationships between plasma levels of matrix metalloproteinases and neurohormonal profile in patients with heart failure.

Authors:  Andrew T Yan; Raymond T Yan; Francis G Spinale; Rizwan Afzal; Himali R Gunasinghe; Robert E Stroud; Robert S McKelvie; Peter P Liu
Journal:  Eur J Heart Fail       Date:  2008-01-29       Impact factor: 15.534

Review 4.  Cardiovascular cell therapy and endogenous repair.

Authors:  D A Taylor; A G Zenovich
Journal:  Diabetes Obes Metab       Date:  2008-11       Impact factor: 6.577

Review 5.  Capturing adenylyl cyclases as potential drug targets.

Authors:  Sandra Pierre; Thomas Eschenhagen; Gerd Geisslinger; Klaus Scholich
Journal:  Nat Rev Drug Discov       Date:  2009-04       Impact factor: 84.694

6.  Transcriptomic profiling of the four adenosine receptors in human leukocytes of heart failure patients.

Authors:  Manuela Cabiati; Raffaele Caruso; Alessandro Verde; Laura Sabatino; Maria-Aurora Morales; Silvia Del Ry
Journal:  Biomed Res Int       Date:  2013-07-08       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.